Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • West Coast Biotech Roundup: Flexus, NGM, Illumina, Bob Klein & More - Xconomy
    CA, was acquired by Bristol-Myers ... will feed NGM’s metabolic drug ... have the option to buy up to 585,000 ... a replacement peptide for ...
    02/26/2015 - 2:28 pm | View Link
  • Stocks to Watch: DISH, Armstrong World Industries, Darden ... - Wall Street Journal
    Bristol-Myers Squibb Co. ...  said Monday it agreed to buy the ... its late-stage diabetes treatment to both ... The Food and Drug ...
    02/23/2015 - 9:42 am | View Link
  • More
  • How To Snag A Drug R&D Partner: 3 Takeaways From Merck's Latest Deal
    It’s been a week of high-profile acquisitions. We saw Bristol-Myers Squibb snap up Flexus Biosciences for its immunotherapy programs. Shire bought Meritage Pharma. After the Allergan flop, Valeant finally got Salix Pharma to go steady, and Ipsen shelled out 6 million euros to buy U.K.-based biotech Canbex. But arguably more attention was placed on one $450 million collaboration than on the ...
    02/27/2015 - 6:07 pm | View Link
  • BUZZ-U.S. STOCKS ON THE MOVE-Biocept, Rigel, Spectrum
    U.S. stocks edged lower in morning trading Monday amid weakness in oil prices, after a conditional agreement by euro zone finance ministers to extend Greece's bailout sent the Dow and S&P to record levels ...
    02/23/2015 - 1:12 pm | View Link
  • 1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
    1 Sentence That Tells You Everything You Need to Know About Each of These 10 Big Pharma Earnings Rep
    02/13/2015 - 8:37 am | View Link
  • Bloomberg the Company
    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
    02/12/2015 - 11:48 pm | View Link
  • More
  • AstraZeneca to buy out Bristol stake in diabetes JV for up to $4.1 bn
    has agreed to buy Bristol-Myers Squibb Co.’s stake in the diabetes ... Last week the venture received a boost when an advisory panel to the US Food and Drug Administration endorsed its new diabetes pill dapagliflozin. Reuters
    12/19/2013 - 5:30 am | View Link
  • Bristol-Myers to buy diabetes drug maker
    NEW YORK (AP) — Bristol-Myers Squibb Co. agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash, heating up the competition among drugmakers to develop diabetes treatments. After the deal is complete, Bristol-Myers will ...
    07/2/2012 - 10:30 am | View Link
  • Bristol-Myers, AZ aim for diabetes glory with Amylin buy
    Now that Bristol-Myers Squibb ($BMY) and AstraZeneca ($AZN) have teamed up to buy Amylin Pharmaceuticals ($AMLN), the ... AstraZeneca will pay Bristol-Myers $3.4 billion for beefing up their current diabetes-drug alliance. Obviously, Astra and Bristol ...
    07/2/2012 - 4:27 am | View Link
  • Bristol-Myers To Buy Amylin Pharmaceuticals
    New York, NY -- Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer. Including Amylin's debt and a ...
    07/1/2012 - 3:40 pm | View Link
  • Bristol-Myers and AstraZeneca team up to buy rival drug maker Amylin
    US pharmaceutical firm Bristol-Myers Squibb has agreed a deal to buy biotechnology company Amylin Pharmaceuticals in a move that will help expand its diabetes treatments portfolio. In an announcement on Friday night, Bristol-Myers said it will pay around $ ...
    07/1/2012 - 1:00 pm | View Link
  • More
  • FDA Accepts New Drug Application for Investigational ...
    Dapagliflozin is a new drug in development for the treatment of type 2 diabetes. Dapagliflozin information includes news, clinical trial results and side effects.
    03/5/2015 - 11:07 pm | View Website
  • U.S. Food and Drug Administration Approves Bristol-Myers ...
    Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved Evotaz (atazanavir 300 mg and cobicistat 150 mg ...
    03/5/2015 - 9:33 pm | View Website
  • Diabetes savings care center buy supplies get rewards ...
    Join for Free. Every 17 seconds, an American is diagnosed with diabetes.** If you or someone you love has diabetes, ExtraCare Advantage for Diabetes is here to help.
    03/5/2015 - 8:12 am | View Website
  • On-line Diabetes Resources: Diabetes Medications Web Sites
    On-line Diabetes Resources Part 11: Diabetes Medications Web Sites By David Mendosa
    03/4/2015 - 6:18 am | View Website
  • Where Can I Get Help Paying for Diabetic Medications? | eHow
    Where Can I Get Help Paying for Diabetic Medications?. Drug companies have recognized that some of their medications are cost prohibitive for many people.
    03/2/2015 - 5:16 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News